-
1
-
-
53549093011
-
Pancreatic beta-cell mass in European subjects with type 2 diabetes
-
Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 2008; 10: 32-42.
-
(2008)
Diabetes Obes Metab
, vol.10
, pp. 32-42
-
-
Rahier, J.1
Guiot, Y.2
Goebbels, R.M.3
Sempoux, C.4
Henquin, J.C.5
-
2
-
-
79957759364
-
Executive Summary: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus
-
Sacks DB, Arnold M, Bakris GL, et al. Executive Summary: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011; 57(6): 793-8.
-
(2011)
Clin Chem
, vol.57
, Issue.6
, pp. 793-798
-
-
Sacks, D.B.1
Arnold, M.2
Bakris, G.L.3
-
3
-
-
84983740425
-
-
American Diabetes Association, National Diabetes Statistics Report
-
American Diabetes Association. Overall Numbers, Diabetes and Prediabetes. National Diabetes Statistics Report 2014.
-
(2014)
Overall Numbers, Diabetes and Prediabetes
-
-
-
4
-
-
33144461460
-
Testing criteria for diagnosis of diabetes mellitus
-
American Diabetes Association
-
American Diabetes Association. Testing criteria for diagnosis of diabetes mellitus. Diabetes Care 2005; 28: S4-36.
-
(2005)
Diabetes Care
, vol.28
, pp. 4-36
-
-
-
5
-
-
78349297565
-
Oxidative stress and diabetic complications
-
Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010; 107(9): 1058-70.
-
(2010)
Circ Res
, vol.107
, Issue.9
, pp. 1058-1070
-
-
Giacco, F.1
Brownlee, M.2
-
6
-
-
20044376702
-
The pathobiology of diabetic complications: A unifying mechanism
-
Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005; 54: 1615-25.
-
(2005)
Diabetes
, vol.54
, pp. 1615-1625
-
-
Brownlee, M.1
-
7
-
-
78651276631
-
Diagnosis and classification of diabetes mellitus
-
American Diabetes Association
-
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34 (Suppl 1): S62-9.
-
(2011)
Diabetes Care
, vol.34
, pp. S62-S69
-
-
-
8
-
-
84922858352
-
Atypical diabetic ketoacidosis: Case report
-
Demirci H, Cosar R, Ciftci O, Sar_ IK. Atypical diabetic ketoacidosis: case report. Balkan Med J 2015; 32(1): 124-6.
-
(2015)
Balkan Med J
, vol.32
, Issue.1
, pp. 124-126
-
-
Demirci, H.1
Cosar, R.2
Ciftci, O.3
Sar, I.K.4
-
9
-
-
84983756030
-
Experimental evidence for curcumin and its analogues for management of diabetes mellitus and its associated complications
-
Rivera MS, Concepcion LM, Pedraza CJ. Experimental evidence for curcumin and its analogues for management of diabetes mellitus and its associated complications. Eur J Pharmacol 2015; S0014-2999(15): 164-8.
-
(2015)
Eur J Pharmacol
, Issue.15
, pp. 164-168
-
-
Rivera, M.S.1
Concepcion, L.M.2
Pedraza, C.J.3
-
10
-
-
84896545275
-
Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management
-
Pappachan JM, Varughese GI, Sriraman R, Arunagirinathan G. Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management. World J Diabetes 2013; 4(5): 177-89.
-
(2013)
World J Diabetes
, vol.4
, Issue.5
, pp. 177-189
-
-
Pappachan, J.M.1
Varughese, G.I.2
Sriraman, R.3
Arunagirinathan, G.4
-
11
-
-
84855185039
-
Standards of medical care in diabetes-2012
-
American Diabetes Association
-
American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care 2012; 35(Suppl 1): S11-63.
-
(2012)
Diabetes Care
, vol.35
, pp. S11-S63
-
-
-
12
-
-
84944679971
-
The values of the new American Diabetes Association Diagnostic Criteria for screening of pre-diabetes and diabetes in patients undergoing elective coronary angiography
-
Zhao X, Ye Y, Zhang S. The values of the new American Diabetes Association Diagnostic Criteria for screening of pre-diabetes and diabetes in patients undergoing elective coronary angiography. Zhonghua Nei Ke Za Zhi 2015; 54(4): 302-6.
-
(2015)
Zhonghua Nei Ke Za Zhi
, vol.54
, Issue.4
, pp. 302-306
-
-
Zhao, X.1
Ye, Y.2
Zhang, S.3
-
14
-
-
0242300698
-
Follow-up report on the diagnosis of diabetes mellitus
-
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
-
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-7.
-
(2003)
Diabetes Care
, vol.26
, pp. 3160-3167
-
-
-
15
-
-
0002552087
-
Classification of diabetes mellitus and other categories of glucose intolerance
-
Zimmet P, Cowie C, Ekoe JM, Shaw JE. Classification of diabetes mellitus and other categories of glucose intolerance. International Textbook of Diabetes Mellitus chapter 1, 3rd Ed. 2004; 3-14.
-
International Textbook of Diabetes Mellitus Chapter 1, 3Rd Ed
, vol.2004
, pp. 3-14
-
-
Zimmet, P.1
Cowie, C.2
Ekoe, J.M.3
Shaw, J.E.4
-
16
-
-
84895500365
-
Prediabetes: The effects on arterial thickness and stiffness in obese youth
-
Shah AS, Gao Z, Urbina EM, Kimball TR, Dolan LM. Prediabetes: the effects on arterial thickness and stiffness in obese youth. J Clin Endocrinol Metab 2014; 99(3): 1037-43.
-
(2014)
J Clin Endocrinol Metab
, vol.99
, Issue.3
, pp. 1037-1043
-
-
Shah, A.S.1
Gao, Z.2
Urbina, E.M.3
Kimball, T.R.4
Dolan, L.M.5
-
17
-
-
84894542402
-
Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes
-
Jorns A, Arndt T, Meyer ZU, et al. Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes. Diabetologia. 2014; 57(3): 512-21.
-
(2014)
Diabetologia
, vol.57
, Issue.3
, pp. 512-521
-
-
Jorns, A.1
Arndt, T.2
Meyer, Z.U.3
-
18
-
-
78049320362
-
Residual insulin production and pancreatic _-cell turnover after 50 years of diabetes: Joslin Medalist Study
-
Keenan HA, Sun JK, Levine J, et al. Residual insulin production and pancreatic _-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 2010; 59: 2846-53.
-
(2010)
Diabetes
, vol.59
, pp. 2846-2853
-
-
Keenan, H.A.1
Sun, J.K.2
Levine, J.3
-
19
-
-
84928406046
-
Pre-POINT Study Group. Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: The Pre-POINT randomized clinical trial
-
Bonifacio E, Ziegler AG, Klingensmith G, et al. Pre-POINT Study Group. Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial. JAMA 2015; 313(15): 1541-9.
-
(2015)
JAMA
, vol.313
, Issue.15
, pp. 1541-1549
-
-
Bonifacio, E.1
Ziegler, A.G.2
Klingensmith, G.3
-
20
-
-
11144298970
-
Insulin resistance is a risk factor for progression to type 1 diabetes
-
Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC. Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 2004; 47: 1661-7.
-
(2004)
Diabetologia
, vol.47
, pp. 1661-1667
-
-
Fourlanos, S.1
Narendran, P.2
Byrnes, G.B.3
Colman, P.G.4
Harrison, L.C.5
-
21
-
-
77951776390
-
Genetics, pathogenesis and clinical interventions in type 1 diabetes
-
Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010; 464(7293): 1293-300.
-
(2010)
Nature
, vol.464
, Issue.7293
, pp. 1293-1300
-
-
Bluestone, J.A.1
Herold, K.2
Eisenbarth, G.3
-
22
-
-
84908173606
-
American Diabetes Association. Care of young children with diabetes in the child care setting: A position statement of the American Diabetes Association
-
Iminerio LM, Albanese NA, Chiang JL, et al. American Diabetes Association. Care of young children with diabetes in the child care setting: a position statement of the American Diabetes Association. Diabetes Care 2014; 37(10): 2834-42.
-
(2014)
Diabetes Care
, vol.37
, Issue.10
, pp. 2834-2842
-
-
Iminerio, L.M.1
Albanese, N.A.2
Chiang, J.L.3
-
23
-
-
84925232478
-
Diabetes Consensus Group. Consensus evidence-based guidelines for insulin therapy in patients with type 1 diabetes mellitus as per Indian clinical practice
-
Kanungo A, Jhingan A, Sahay RK, Muruganathan A, Das AK. Diabetes Consensus Group. Consensus evidence-based guidelines for insulin therapy in patients with type 1 diabetes mellitus as per Indian clinical practice. J Assoc Physicians India 2014; 62(7): 26-33.
-
(2014)
J Assoc Physicians India
, vol.62
, Issue.7
, pp. 26-33
-
-
Kanungo, A.1
Jhingan, A.2
Sahay, R.K.3
Muruganathan, A.4
Das, A.K.5
-
24
-
-
33744482034
-
Insulin resistance and metabolic syndrome in type 1 diabetes mellitus
-
Dib SA. Insulin resistance and metabolic syndrome in type 1 diabetes mellitus. Arq Bras Endocrinol Metabol 2006; 50: 250-63.
-
(2006)
Arq Bras Endocrinol Metabol
, vol.50
, pp. 250-263
-
-
Dib, S.A.1
-
25
-
-
77952094084
-
The use of metformin in type 1 diabetes: A systematic review of efficacy
-
Vella S, Buetow L, Royle P, Livingstone S, Colhoun HM, Petrie JR. The use of metformin in type 1 diabetes: A systematic review of efficacy. Diabetologia 2010; 53: 809-20.
-
(2010)
Diabetologia
, vol.53
, pp. 809-820
-
-
Vella, S.1
Buetow, L.2
Royle, P.3
Livingstone, S.4
Colhoun, H.M.5
Petrie, J.R.6
-
26
-
-
43249092146
-
Adjunctive therapies to glycaemic control of type 1 diabetes mellitus
-
Gabbay MA. Adjunctive therapies to glycaemic control of type 1 diabetes mellitus. Arq Bras Endocrinol Metabol 2008; 52: 279-87.
-
(2008)
Arq Bras Endocrinol Metabol
, vol.52
, pp. 279-287
-
-
Gabbay, M.A.1
-
27
-
-
77952297607
-
Diabetes mellitus: Diagnosis and screening
-
Patel P, Macerollo A. Diabetes mellitus: diagnosis and screening. Am Fam Physician 2010; 81: 863-70.
-
(2010)
Am Fam Physician
, vol.81
, pp. 863-870
-
-
Patel, P.1
Macerollo, A.2
-
28
-
-
84907779022
-
Consensus guidelines for glycemic monitoring in type 1/type 2 & GDM
-
Kesavadev J, Sadikot S, Wangnoo S, et al. Consensus guidelines for glycemic monitoring in type 1/type 2 & GDM. Diabetes Metab Syndr 2014; 8(3): 187-95.
-
(2014)
Diabetes Metab Syndr
, vol.8
, Issue.3
, pp. 187-195
-
-
Kesavadev, J.1
Sadikot, S.2
Wangnoo, S.3
-
29
-
-
41849103788
-
The gap between guidelines and practice in the treatment of type 2 diabetes. A nationwide survey in Norway
-
Jenssen TG, Tonstad S, Claudi T, Midthjell K, Cooper J. The gap between guidelines and practice in the treatment of type 2 diabetes. A nationwide survey in Norway. Diabetes Res Clin Pract 2008; 80: 314-20.
-
(2008)
Diabetes Res Clin Pract
, vol.80
, pp. 314-320
-
-
Jenssen, T.G.1
Tonstad, S.2
Claudi, T.3
Midthjell, K.4
Cooper, J.5
-
30
-
-
84959370430
-
Association of parental history of type 2 diabetes with age, lifestyle, anthropometric factors, and clinical severity at type 2 diabetes diagnosis: Results from the DD2 study
-
Svensson E, Berencsi K, Sander S, et al. Association of parental history of type 2 diabetes with age, lifestyle, anthropometric factors, and clinical severity at type 2 diabetes diagnosis: results from the DD2 study. Diabetes Metab Res Rev 2015.
-
(2015)
Diabetes Metab Res Rev
-
-
Svensson, E.1
Berencsi, K.2
Sander, S.3
-
31
-
-
0034106347
-
Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: Prospective results from the Massachusetts male aging study
-
Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 2000; 23(4): 490-4.
-
(2000)
Diabetes Care
, vol.23
, Issue.4
, pp. 490-494
-
-
Stellato, R.K.1
Feldman, H.A.2
Hamdy, O.3
Horton, E.S.4
McKinlay, J.B.5
-
32
-
-
0346728590
-
Sex hormones, inflammation and the metabolic syndrome: A population-based study
-
Laaksonen DE, Niskanen L, Punnonen K, et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 2003; 149: 601-8.
-
(2003)
Eur J Endocrinol
, vol.149
, pp. 601-608
-
-
Laaksonen, D.E.1
Niskanen, L.2
Punnonen, K.3
-
33
-
-
2342644814
-
Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men
-
Laaksonen DE, Niskanen L, Punnonen K, et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004; 27(5): 1036-41.
-
(2004)
Diabetes Care
, vol.27
, Issue.5
, pp. 1036-1041
-
-
Laaksonen, D.E.1
Niskanen, L.2
Punnonen, K.3
-
34
-
-
24144493455
-
Androgens, insulin resistance and vascular disease in men
-
Kapoor D, Malkin CJ, Channer KS, Jones TH. Androgens, insulin resistance and vascular disease in men. Clin Endocrinol (Oxf) 2005; 63: 239-250.
-
(2005)
Clin Endocrinol (Oxf)
, vol.63
, pp. 239-250
-
-
Kapoor, D.1
Malkin, C.J.2
Channer, K.S.3
Jones, T.H.4
-
35
-
-
84863779987
-
Prevention of type 2 diabetes and its complications in developing countries: A review
-
Rawal LB, Tapp RJ, Williams ED, Chan C, Yasin S, Oldenburg B. Prevention of type 2 diabetes and its complications in developing countries: a review. Int J Behav Med 2012; 19(2): 121-33.
-
(2012)
Int J Behav Med
, vol.19
, Issue.2
, pp. 121-133
-
-
Rawal, L.B.1
Tapp, R.J.2
Williams, E.D.3
Chan, C.4
Yasin, S.5
Oldenburg, B.6
-
36
-
-
0041668076
-
Rapid increase in the use of oral anti-diabetic drugs in the United States
-
Wysowski DK, Armstrong G, Governale L. Rapid increase in the use of oral anti-diabetic drugs in the United States. Diabetes Care 2003; 26(6): 1852-5.
-
(2003)
Diabetes Care
, vol.26
, Issue.6
, pp. 1852-1855
-
-
Wysowski, D.K.1
Armstrong, G.2
Governale, L.3
-
37
-
-
84858225542
-
Novel pharmacological approaches to the treatment of type 2 diabetes
-
Verspohl EJ. Novel pharmacological approaches to the treatment of type 2 diabetes. Pharmacol Rev 2012; 64(2): 188-237.
-
(2012)
Pharmacol Rev
, vol.64
, Issue.2
, pp. 188-237
-
-
Verspohl, E.J.1
-
38
-
-
79956351014
-
Diabetes and Endocrinology Meta-analysis Group (DEMA). Effect of anti-hyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: A network meta-analysis
-
Gross JL, Kramer CK, Leitao CB, et al. Diabetes and Endocrinology Meta-analysis Group (DEMA). Effect of anti-hyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis. Ann Intern Med 2011; 154(10): 672-9.
-
(2011)
Ann Intern Med
, vol.154
, Issue.10
, pp. 672-679
-
-
Gross, J.L.1
Kramer, C.K.2
Leitao, C.B.3
-
39
-
-
84888091849
-
The role of meglitinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus
-
Guardado MR, Prioletta A, Jimenez LM, Sosale A, Folli F. The role of meglitinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus. Arch Med Sci 2013; 9(5): 936-43.
-
(2013)
Arch Med Sci
, vol.9
, Issue.5
, pp. 936-943
-
-
Guardado, M.R.1
Prioletta, A.2
Jimenez, L.M.3
Sosale, A.4
Folli, F.5
-
40
-
-
77950891085
-
Effect of noninsulin anti-diabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes
-
Phung OJ, Scholle JM, Talwar M, Coleman CI. Effect of noninsulin anti-diabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. JAMA 2010; 303(14): 1410-8.
-
(2010)
JAMA
, vol.303
, Issue.14
, pp. 1410-1418
-
-
Phung, O.J.1
Scholle, J.M.2
Talwar, M.3
Coleman, C.I.4
-
41
-
-
0023217040
-
The effect of short-term alpha-glucosidase inhibition on carbohydrate and lipid metabolism in type II (Noninsulin-dependent) diabetics
-
Baron AD, Eckel RH, Schmeiser L, Kolterman OG. The effect of short-term alpha-glucosidase inhibition on carbohydrate and lipid metabolism in type II (noninsulin-dependent) diabetics. Metabolism 1987; 36(5): 409-15.
-
(1987)
Metabolism
, vol.36
, Issue.5
, pp. 409-415
-
-
Baron, A.D.1
Eckel, R.H.2
Schmeiser, L.3
Kolterman, O.G.4
-
42
-
-
84911869595
-
Thiazolidinedione and metformin use and the risk of benign prostate hyperplasia in veterans with diabetes mellitus
-
Murff HJ, Roumie CL, Greevy RA, et al. Thiazolidinedione and metformin use and the risk of benign prostate hyperplasia in veterans with diabetes mellitus. J Mens Health 2014; 11(4): 157-62.
-
(2014)
J Mens Health
, vol.11
, Issue.4
, pp. 157-162
-
-
Murff, H.J.1
Roumie, C.L.2
Greevy, R.A.3
-
43
-
-
84930625022
-
Design, synthesis, and pharmacological evaluation of highly potent and selective dipeptidyl peptidase-4 inhibitors
-
Jiang T, Zhou Y, Zhu J, et al. Design, synthesis, and pharmacological evaluation of highly potent and selective dipeptidyl peptidase-4 inhibitors. Arch Pharm (Weinheim) 2015.
-
(2015)
Arch Pharm (Weinheim)
-
-
Jiang, T.1
Zhou, Y.2
Zhu, J.3
-
44
-
-
55849133043
-
Diabetes-related microvascular and macrovascular diseases in the physical therapy setting
-
Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther 2008; 88: 1322-1335.
-
(2008)
Phys Ther
, vol.88
, pp. 1322-1335
-
-
Cade, W.T.1
-
45
-
-
33244486544
-
Diagnosis and classification of diabetes mellitus
-
American Diabetes Association
-
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006; 29: S43-8.
-
(2006)
Diabetes Care
, vol.29
, pp. S43-S48
-
-
-
46
-
-
79956149078
-
Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes: A systematic review and meta-analysis of the European Depression in Diabetes (EDID) Research Consortium
-
Nouwen A, Nefs G, Caramlau I, et al. Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes: a systematic review and meta-analysis of the European Depression in Diabetes (EDID) Research Consortium. Diabetes Care 2011; 34: 752-62.
-
(2011)
Diabetes Care
, vol.34
, pp. 752-762
-
-
Nouwen, A.1
Nefs, G.2
Caramlau, I.3
-
47
-
-
77954685773
-
Diabetes, sexual dysfunction and therapeutic exercise: A 20 year review
-
Adeniyi AF, Adeleye JO, Adeniyi CY. Diabetes, sexual dysfunction and therapeutic exercise: a 20 year review. Curr Diabetes Rev 2011; 6: 201-206.
-
(2011)
Curr Diabetes Rev
, vol.6
, pp. 201-206
-
-
Adeniyi, A.F.1
Adeleye, J.O.2
Adeniyi, C.Y.3
-
48
-
-
28444491100
-
Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies
-
Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 2005; 48: 2460-9.
-
(2005)
Diabetologia
, vol.48
, pp. 2460-2469
-
-
Cukierman, T.1
Gerstein, H.C.2
Williamson, J.D.3
-
49
-
-
79952316254
-
Diabetes induced erectile dysfunction: Epidemiology, pathophysiology and management
-
Thorve VS, Kshirsagar AD, Vyawahare NS, Joshi VS, Ingale KG, Mohite RJ. Diabetes induced erectile dysfunction: epidemiology, pathophysiology and management. J Diabetes Complications 2011; 25: 129-36.
-
(2011)
J Diabetes Complications
, vol.25
, pp. 129-136
-
-
Thorve, V.S.1
Kshirsagar, A.D.2
Vyawahare, N.S.3
Joshi, V.S.4
Ingale, K.G.5
Mohite, R.J.6
-
50
-
-
84901484726
-
The associations of epicardial adipose tissue with coronary artery disease and coronary atherosclerosis
-
Kim SH, Chung JH, Kwon BJ, Song SW, Choi WS. The associations of epicardial adipose tissue with coronary artery disease and coronary atherosclerosis. Int Heart J 2014; 55(3): 197-203.
-
(2014)
Int Heart J
, vol.55
, Issue.3
, pp. 197-203
-
-
Kim, S.H.1
Chung, J.H.2
Kwon, B.J.3
Song, S.W.4
Choi, W.S.5
-
51
-
-
17044386953
-
Type 2 diabetes: Principles of pathogenesis and therapy
-
Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005; 365: 1333-46.
-
(2005)
Lancet
, vol.365
, pp. 1333-1346
-
-
Stumvoll, M.1
Goldstein, B.J.2
Van Haeften, T.W.3
-
52
-
-
33748368261
-
Receptor for advanced glycation end products and the cardiovascular complications of diabetes and beyond: Lessons from AGEing
-
Yan SF, Yan SD, Herold K, Ramsamy R, Schmidt AM. Receptor for advanced glycation end products and the cardiovascular complications of diabetes and beyond: lessons from AGEing. Endocrinol Metab Clin North Am 2006; 35(3): 511-24.
-
(2006)
Endocrinol Metab Clin North Am
, vol.35
, Issue.3
, pp. 511-524
-
-
Yan, S.F.1
Yan, S.D.2
Herold, K.3
Ramsamy, R.4
Schmidt, A.M.5
-
53
-
-
84941091323
-
A novel carboxymethylated mercaptotriazinoindole inhibitor of aldose reductase interferes with the polyol pathway in streptozotocininduced diabetic rats
-
Soltesova PM, Ballekova J, Gajdosikova A, Gajdosik A, Stefek M. A novel carboxymethylated mercaptotriazinoindole inhibitor of aldose reductase interferes with the polyol pathway in streptozotocininduced diabetic rats. Physiol Res 2015; 64(4): 587-91.
-
(2015)
Physiol Res
, vol.64
, Issue.4
, pp. 587-591
-
-
Soltesova, P.M.1
Ballekova, J.2
Gajdosikova, A.3
Gajdosik, A.4
Stefek, M.5
-
54
-
-
84983793151
-
-
Lather V, Sekhon BS. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases. Mini Rev Med Chem
-
Grewal AS, Bhardwaj S, Pandita D, Lather V, Sekhon BS. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases. Mini Rev Med Chem 2015 Sep 9.
-
(2015)
Pandita D
, pp. 9
-
-
Grewal, A.S.1
Bhardwaj, S.2
-
55
-
-
84863847452
-
Aldose reductase, oxidative stress and diabetes mellitus
-
Tang WH, Martin KA, Hwa J. Aldose reductase, oxidative stress and diabetes mellitus. Front Pharmacol 2012; 3: 1-8.
-
(2012)
Front Pharmacol
, vol.3
, pp. 1-8
-
-
Tang, W.H.1
Martin, K.A.2
Hwa, J.3
-
57
-
-
80052059557
-
AGE restriction in diabetes mellitus: A paradigm shift
-
Vlassara, Striker GE. AGE restriction in diabetes mellitus: a paradigm shift. Nat Rev Endocrinol 2011; 7: 526-39.
-
(2011)
Nat Rev Endocrinol
, vol.7
, pp. 526-539
-
-
Vlassara, S.G.1
-
58
-
-
84983778654
-
Carboxymethyl lysine, an advanced glycation end product, andincident diabetes: A casecohort analysis of the ARIC Study
-
Luft VC, Duncan BB, Schmidt MI, et al. Carboxymethyl lysine, an advanced glycation end product, andincident diabetes: a casecohort analysis of the ARIC Study. Diabet Med 2015.
-
(2015)
Diabet Med
-
-
Luft, V.C.1
Duncan, B.B.2
Schmidt, M.I.3
-
59
-
-
36248989151
-
Advanced glycation end-products (AGEs) and heart failure: Pathophysiology and clinical implications
-
Hartog JW, Voors AA, Bakker SJ, Smit AJ, Veldhuisen DJ. Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications. Eur J Heart Fail 2007; 9: 1146-1155.
-
(2007)
Eur J Heart Fail
, vol.9
, pp. 1146-1155
-
-
Hartog, J.W.1
Voors, A.A.2
Bakker, S.J.3
Smit, A.J.4
Veldhuisen, D.J.5
-
60
-
-
0028908348
-
Advanced protein glycosylation in diabetes and aging
-
Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1995; 46: 223-34.
-
(1995)
Annu Rev Med
, vol.46
, pp. 223-234
-
-
Brownlee, M.1
-
61
-
-
4043058031
-
Advanced glycation end productsand vascular inflammation: Implications for accelerated atherosclerosisin diabetes
-
Basta G, Schmidt AM, De Caterina R. Advanced glycation end productsand vascular inflammation: implications for accelerated atherosclerosisin diabetes. Cardiovasc Res 2004; 63: 582-92.
-
(2004)
Cardiovasc Res
, vol.63
, pp. 582-592
-
-
Basta, G.1
Schmidt, A.M.2
De Caterina, R.3
-
62
-
-
0028587238
-
Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins
-
Schmidt AM, Hasu M, Popov D, et al. Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc Natl Acad Sci USA 1994; 91: 8807-11.
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 8807-8811
-
-
Schmidt, A.M.1
Hasu, M.2
Popov, D.3
-
63
-
-
84923275299
-
Dicarbonyl stress in cell and tissue dysfunction contributing to ageing and disease
-
Rabbani N, Thornalley PJ. Dicarbonyl stress in cell and tissue dysfunction contributing to ageing and disease. Biochem Biophys Res Commun 2015; 458(2): 221-6.
-
(2015)
Biochem Biophys Res Commun
, vol.458
, Issue.2
, pp. 221-226
-
-
Rabbani, N.1
Thornalley, P.J.2
-
65
-
-
23644448608
-
Advanced glycation end products (AGEs) and diabetic vascular complications
-
Yamagishi S, Nakamura K, Imaizumi T. Advanced glycation end products (AGEs) and diabetic vascular complications. Curr Diabetes Rev 2005; 1(1): 93-106.
-
(2005)
Curr Diabetes Rev
, vol.1
, Issue.1
, pp. 93-106
-
-
Yamagishi, S.1
Nakamura, K.2
Imaizumi, T.3
-
66
-
-
77956399885
-
SRAGE induces human monocyte survival and differentiation
-
Wang Y, Wang H, Piper MG, et al. SRAGE induces human monocyte survival and differentiation. J Immunol 2010; 185(3): 1822-35.
-
(2010)
J Immunol
, vol.185
, Issue.3
, pp. 1822-1835
-
-
Wang, Y.1
Wang, H.2
Piper, M.G.3
-
67
-
-
0026451081
-
Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C
-
Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992; 258: 607-14.
-
(1992)
Science
, vol.258
, pp. 607-614
-
-
Nishizuka, Y.1
-
68
-
-
0029060391
-
Protein kinase C and lipid signaling for sustained cellular responses
-
Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB 1995; 9: 484-96.
-
(1995)
FASEB
, vol.9
, pp. 484-496
-
-
Nishizuka, Y.1
-
69
-
-
0028265959
-
Lipid second messengers
-
Liscovitch M, Cantley LC. Lipid second messengers. Cell 1994; 77: 329-34.
-
(1994)
Cell
, vol.77
, pp. 329-334
-
-
Liscovitch, M.1
Cantley, L.C.2
-
70
-
-
0000922621
-
Diabetic vascular dysfunctions: A model of excessive activation of protein kinase C
-
King GL, Ishii H, Koya D. Diabetic vascular dysfunctions: A model of excessive activation of protein kinase C. Kidney Int 1997; 60: S77-85.
-
(1997)
Kidney Int
, vol.60
, pp. S77-S85
-
-
King, G.L.1
Ishii, H.2
Koya, D.3
-
71
-
-
0035669720
-
Protein kinase C and the development of diabetic vascular complications
-
Way KJ, Katai N, King GL. Protein kinase C and the development of diabetic vascular complications. Diabet Med 2001; 18: 945-59.
-
(2001)
Diabet Med
, vol.18
, pp. 945-959
-
-
Way, K.J.1
Katai, N.2
King, G.L.3
-
72
-
-
7044231909
-
Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway
-
Thallas BV, Lindschau C, Rizkalla B, et al. Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway. Diabetes 2004; 53(11): 2921-30.
-
(2004)
Diabetes
, vol.53
, Issue.11
, pp. 2921-2930
-
-
Thallas, B.V.1
Lindschau, C.2
Rizkalla, B.3
-
73
-
-
84875481512
-
Oxidative-stress-induced epigenetic changes in chronic diabetic complications
-
Feng B, Ruiz MA, Chakrabarti S. Oxidative-stress-induced epigenetic changes in chronic diabetic complications. Can J Physiol Pharmacol 2013; 91(3): 213-20.
-
(2013)
Can J Physiol Pharmacol
, vol.91
, Issue.3
, pp. 213-220
-
-
Feng, B.1
Ruiz, M.A.2
Chakrabarti, S.3
-
74
-
-
0031975643
-
High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells
-
Kolm LV, Sauer U, Nerlich A, Lehmann R, Schleicher ED. High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 1998; 101: 160-9.
-
(1998)
J Clin Invest
, vol.101
, pp. 160-169
-
-
Kolm, L.V.1
Sauer, U.2
Nerlich, A.3
Lehmann, R.4
Schleicher, E.D.5
-
75
-
-
0037524357
-
O-GlcNAc turns twenty: Functional implications for posttranslational modification of nuclear and cytosolic protein with a sugar
-
Wells L, Hart G. O-GlcNAc turns twenty: functional implications for posttranslational modification of nuclear and cytosolic protein with a sugar. FEBS Lett 2003; 546: 154-8.
-
(2003)
FEBS Lett
, vol.546
, pp. 154-158
-
-
Wells, L.1
Hart, G.2
-
76
-
-
84939898433
-
The consequences of failure to achieve targets of guidelines for prevention and treatment of diabetic complications in patients with type 1 diabetes
-
Lithovius R, Harjutsalo V, Forsblom C, Saraheimo M, Groop PH. The consequences of failure to achieve targets of guidelines for prevention and treatment of diabetic complications in patients with type 1 diabetes. Acta Diabetol 2014; 52: 31-8.
-
(2014)
Acta Diabetol
, vol.52
, pp. 31-38
-
-
Lithovius, R.1
Harjutsalo, V.2
Forsblom, C.3
Saraheimo, M.4
Groop, P.H.5
-
77
-
-
84906040999
-
Effects of advanced glycation end products on calcium handling in cardiomyocytes
-
Yan D, Luo X, Li Y, et al. Effects of advanced glycation end products on calcium handling in cardiomyocytes. Cardiology 2014; 129(2): 75-83.
-
(2014)
Cardiology
, vol.129
, Issue.2
, pp. 75-83
-
-
Yan, D.1
Luo, X.2
Li, Y.3
-
78
-
-
59149100896
-
Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): Cardiovascular implications
-
Lindsey JB, Cipollone F, Abdullah SM, et al. Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications. Diab Vasc Dis Res 2009; 6: 7-14.
-
(2009)
Diab Vasc Dis Res
, vol.6
, pp. 7-14
-
-
Lindsey, J.B.1
Cipollone, F.2
Abdullah, S.M.3
-
79
-
-
84896528860
-
Advanced glycation end products and diabetic complications
-
Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol 2014; 18(1): 1-14.
-
(2014)
Korean J Physiol Pharmacol
, vol.18
, Issue.1
, pp. 1-14
-
-
Singh, V.P.1
Bali, A.2
Singh, N.3
Jaggi, A.S.4
-
80
-
-
0035851210
-
Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly (ADP ribose) polymerase
-
Soriano FG, Pacher P, Mabley J, Liaudet L, Szabo C. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly (ADP ribose) polymerase. Circ Res 2001; 89, 684-69152.
-
(2001)
Circ Res
, vol.89
, pp. 684-69152
-
-
Soriano, F.G.1
Pacher, P.2
Mabley, J.3
Liaudet, L.4
Szabo, C.5
-
81
-
-
0035810983
-
Glycaemic control and heart failure among adult patients with diabetes
-
Iribarren C, Karter AJ, Go AS, et al. Glycaemic control and heart failure among adult patients with diabetes. Circulation 2001; 103: 2668-267353.
-
(2001)
Circulation
, vol.103
, pp. 2668-267353
-
-
Iribarren, C.1
Karter, A.J.2
Go, A.S.3
-
82
-
-
0030875166
-
Targeted over expression of protein kinase C beta 2 isoform in myocardium causes cardiomyopathy
-
Wakasaki H, Koya D, Schoen FJ, et al. Targeted over expression of protein kinase C beta 2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci USA 1997; 94: 9320-5.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 9320-9325
-
-
Wakasaki, H.1
Koya, D.2
Schoen, F.J.3
-
83
-
-
84929946877
-
Anderson EJ. Obesity in a model of gpx4 haplo insufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy
-
Katunga LA, Gudimella P, Efird JT, et al. Anderson EJ. Obesity in a model of gpx4 haplo insufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy. Mol Metab 2015; 4(6): 493-506.
-
(2015)
Mol Metab
, vol.4
, Issue.6
, pp. 493-506
-
-
Katunga, L.A.1
Gudimella, P.2
Efird, J.T.3
-
84
-
-
84872313601
-
Mechanisms of diabetic complications
-
Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev 2013; 93(1): 137-88.
-
(2013)
Physiol Rev
, vol.93
, Issue.1
, pp. 137-188
-
-
Forbes, J.M.1
Cooper, M.E.2
-
85
-
-
0036248879
-
Management of co-existing diabetes mellitus and dyslipidemia: Defining the role of thiazolidinediones
-
Florkowski CM. Management of co-existing diabetes mellitus and dyslipidemia: defining the role of thiazolidinediones. Am J Cardiovasc 2002; 2: 15-21.
-
(2002)
Am J Cardiovasc
, vol.2
, pp. 15-21
-
-
Florkowski, C.M.1
-
86
-
-
84927786175
-
Diabetic macrovascular complications
-
Yamagishi S. Diabetic macrovascular complications. Nihon Rinsho. 2015; 73(3): 479-83.
-
(2015)
Nihon Rinsho
, vol.73
, Issue.3
, pp. 479-483
-
-
Yamagishi, S.1
-
87
-
-
0032989116
-
Effects of glucose intolerance on myocardial function and collagen-linked glycation
-
Avendano GF, Agarwal RK, Bashey RI, et al. Effects of glucose intolerance on myocardial function and collagen-linked glycation. Diabetes 1999; 48; 1443-7.
-
(1999)
Diabetes
, vol.48
, pp. 1443-1447
-
-
Avendano, G.F.1
Agarwal, R.K.2
Bashey, R.I.3
-
88
-
-
0032511583
-
Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes UKPDS 33
-
UK Prospective Diabetes Study (UKPDS) Group
-
UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes UKPDS 33. Lancet 1998; 352: 837-53.
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
89
-
-
0034709738
-
Seeing what you want to see in randomized controlled trials: Versions and perversions of UKPDS data. United Kingdom prospective diabetes study
-
McCormack J, Greenhalgh T. Seeing what you want to see in randomized controlled trials: versions and perversions of UKPDS data. United Kingdom prospective diabetes study. Br Med J 2000; 320: 1720-3.
-
(2000)
Br Med J
, vol.320
, pp. 1720-1723
-
-
McCormack, J.1
Greenhalgh, T.2
-
90
-
-
84983806644
-
Individualised risk assessment for diabetic retinopathy and optimisation of screening intervals: A scientific approach to reducing healthcare costs
-
Lund SH, Aspelund T, Kirby P, et al. Individualised risk assessment for diabetic retinopathy and optimisation of screening intervals: a scientific approach to reducing healthcare costs. Br J Ophthalmol 2015; 307-41.
-
(2015)
Br J Ophthalmol
, pp. 307-341
-
-
Lund, S.H.1
Aspelund, T.2
Kirby, P.3
-
91
-
-
84928638252
-
Blood pressure is a risk factor for progression of diabetic retinopathy in normotensive patients with type 2 diabetes: Correlation with carotid intima-media thickness
-
Saif A, Karawya S, Abdelhamid A. Blood pressure is a risk factor for progression of diabetic retinopathy in normotensive patients with type 2 diabetes: correlation with carotid intima-media thickness. Endocr Regul 2014; 48(4): 189-94.
-
(2014)
Endocr Regul
, vol.48
, Issue.4
, pp. 189-194
-
-
Saif, A.1
Karawya, S.2
Abdelhamid, A.3
-
93
-
-
0033400347
-
The pathogenesis of edema in diabetic maculopathy
-
Antcliff RJ, Marshall J. The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol 1999; 14(4): 223-32.
-
(1999)
Semin Ophthalmol
, vol.14
, Issue.4
, pp. 223-232
-
-
Antcliff, R.J.1
Marshall, J.2
-
94
-
-
84859030420
-
Meta-Analysis for Eye Disease (METAEYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy
-
Yau JW, Rogers SL, Kawasaki R, et al. Meta-Analysis for Eye Disease (METAEYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012; 35: 556-64.
-
(2012)
Diabetes Care
, vol.35
, pp. 556-564
-
-
Yau, J.W.1
Rogers, S.L.2
Kawasaki, R.3
-
95
-
-
84940875935
-
Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy
-
Wan TT, Li XF, Sun YM, Li YB, Su Y. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. Biomed Pharmacother 2015; 74: 145-7.
-
(2015)
Biomed Pharmacother
, vol.74
, pp. 145-147
-
-
Wan, T.T.1
Li, X.F.2
Sun, Y.M.3
Li, Y.B.4
Su, Y.5
-
96
-
-
84975661776
-
Role of crystallins in diabetic complications
-
S0304-4165(15)00148-8
-
Reddy VS, Reddy GB. Role of crystallins in diabetic complications. Biochim Biophys Acta 2015; S0304-4165(15)00148-8.
-
(2015)
Biochim Biophys Acta
-
-
Reddy, V.S.1
Reddy, G.B.2
-
97
-
-
84943170941
-
Plasma Fibrinogen in Type 2 Diabetic Patients with Metabolic Syndrome and its Relationwith Ischemic Heart Disease (IHD) and Retinopathy
-
BC18-21
-
Mahendra JV, Kumar SD, Anuradha TS, Talikoti P, Nagaraj RS, Vishali V. Plasma Fibrinogen in Type 2 Diabetic Patients with Metabolic Syndrome and its Relationwith Ischemic Heart Disease (IHD) and Retinopathy. J Clin Diagn Res 2015; 9(1): BC18-21.
-
(2015)
J Clin Diagn Res
, vol.9
, Issue.1
-
-
Mahendra, J.V.1
Kumar, S.D.2
Anuradha, T.S.3
Talikoti, P.4
Nagaraj, R.S.5
Vishali, V.6
-
98
-
-
84945529430
-
CRIC study investigators. Retinopathy and the risk of cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study)
-
S0002-9149(15)01842-1
-
Grunwald JE, Pistilli M, Ying GS, et al. CRIC study investigators. Retinopathy and the risk of cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study). Am J Cardiol 2015; S0002-9149(15)01842-1.
-
(2015)
Am J Cardiol
-
-
Grunwald, J.E.1
Pistilli, M.2
Ying, G.S.3
-
99
-
-
84942411845
-
Anti-vascular endothelial growth factor therapy for proliferative diabetic retinopathy: A systematic review and meta-analysis
-
Simunovic MP, Maberley DA. Anti-vascular endothelial growth factor therapy for proliferative diabetic retinopathy: a systematic review and meta-analysis. Retina 2015; 35(10): 1931-42.
-
(2015)
Retina
, vol.35
, Issue.10
, pp. 1931-1942
-
-
Simunovic, M.P.1
Maberley, D.A.2
-
100
-
-
7144227270
-
Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy
-
Yamaguchi M, Nakamura N, Nakano K, et al. Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy. Diabet Med 1998; 15: 458-62.
-
(1998)
Diabet Med
, vol.15
, pp. 458-462
-
-
Yamaguchi, M.1
Nakamura, N.2
Nakano, K.3
-
101
-
-
84884230968
-
Identification of novel drug targets for the treatment of diabetic retinopathy
-
Uemura A. Identification of novel drug targets for the treatment of diabetic retinopathy. Diabetes Metab J 2013; 37: 217-24.
-
(2013)
Diabetes Metab J
, vol.37
, pp. 217-224
-
-
Uemura, A.1
-
102
-
-
58149166482
-
Blockade of sphingosine 1 phosphate reduces macrophage influx and retinal and choroidal neovascularization
-
Xie B, Shen J, Dong A, et al. Blockade of sphingosine 1 phosphate reduces macrophage influx and retinal and choroidal neovascularization. J Cell Physiol 2009; 218(1): 192-8.
-
(2009)
J Cell Physiol
, vol.218
, Issue.1
, pp. 192-198
-
-
Xie, B.1
Shen, J.2
Dong, A.3
-
103
-
-
80053027076
-
Expression and cellular localization of microRNA-29b and RAX, an activator of the RNAdependent protein kinase (PKR), in the retina of streptozotocininduced diabetic rats
-
Silva VA, Polesskaya A, Sousa TA, et al. Expression and cellular localization of microRNA-29b and RAX, an activator of the RNAdependent protein kinase (PKR), in the retina of streptozotocininduced diabetic rats. Mol Vis 2011; 17: 2228-40.
-
(2011)
Mol Vis
, vol.17
, pp. 2228-2240
-
-
Silva, V.A.1
Polesskaya, A.2
Sousa, T.A.3
-
104
-
-
0034741275
-
N (Epsilon)-(carboxymethyl) lysine levels in patients with type 2 diabetes: Role of renal function
-
Wagner Z, Wittmann I, Mazak I, et al. N (epsilon)-(carboxymethyl) lysine levels in patients with type 2 diabetes: role of renal function. Am J Kidney Dis 2001; 38: 785-91.
-
(2001)
Am J Kidney Dis
, vol.38
, pp. 785-791
-
-
Wagner, Z.1
Wittmann, I.2
Mazak, I.3
-
105
-
-
33645276928
-
Projecting the number of patients with end-stage renal disease in the United States to the year 2015
-
Gilbertson DT, Liu J, Xue JL, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol 2005; 16: 3736-41.
-
(2005)
J am Soc Nephrol
, vol.16
, pp. 3736-3741
-
-
Gilbertson, D.T.1
Liu, J.2
Xue, J.L.3
-
106
-
-
77953291706
-
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis
-
Matsushita K. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375(9731): 2073-81.
-
(2010)
Lancet
, vol.375
, Issue.9731
, pp. 2073-2081
-
-
Matsushita, K.1
-
107
-
-
79751477368
-
Glimpse of various pathogenic mechanisms of diabetic nephropathy
-
Kanwar YS, Sun LA. Glimpse of various pathogenic mechanisms of diabetic nephropathy. Annu Rev Pathol Mech Dis 2011; 6: 395-423.
-
(2011)
Annu Rev Pathol Mech Dis
, vol.6
, pp. 395-423
-
-
Kanwar, Y.S.1
Sun, L.A.2
-
108
-
-
85015500605
-
Management of diabetic renal disease
-
Eboh C, Chowdhury TA. Management of diabetic renal disease. Ann Transl Med 2015; 3(11): 154.
-
(2015)
Ann Transl Med
, vol.3
, Issue.11
, pp. 154
-
-
Eboh, C.1
Chowdhury, T.A.2
-
109
-
-
84902179695
-
Cellular and molecular mechanisms in kidney fibrosis
-
Duffield JS. Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest 2014; 124(6): 2299-306.
-
(2014)
J Clin Invest
, vol.124
, Issue.6
, pp. 2299-2306
-
-
Duffield, J.S.1
-
110
-
-
66449121454
-
Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models
-
Brooks C, Wei Q, Cho SG, Dong Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest 2009; 119: 1275-85.
-
(2009)
J Clin Invest
, vol.119
, pp. 1275-1285
-
-
Brooks, C.1
Wei, Q.2
Cho, S.G.3
Dong, Z.4
-
111
-
-
84945902510
-
Chronic running exercise alleviates early progression of nephropathy with upregulation of nitric oxide synthases and suppression of glycation in zucker diabetic rats
-
Ito D, Cao P, Kakihana T, et al. Chronic running exercise alleviates early progression of nephropathy with upregulation of nitric oxide synthases and suppression of glycation in zucker diabetic rats. PLoS One 2015; 10 (9): 138037.
-
(2015)
Plos One
, vol.10
, Issue.9
, pp. 138037
-
-
Ito, D.1
Cao, P.2
Kakihana, T.3
-
113
-
-
84983770589
-
Can targeting the incretin pathway dampen RAGE-mediated events in diabetic nephropathy?
-
Sourris KC, Yao H, Jerums G, Cooper ME, Ekinci EI, Coughlan MT. Can targeting the incretin pathway dampen RAGE-mediated events in diabetic nephropathy? Curr Drug Targets 2016; 17(11): 1252-64.
-
(2016)
Curr Drug Targets
, vol.17
, Issue.11
, pp. 1252-1264
-
-
Sourris, K.C.1
Yao, H.2
Jerums, G.3
Cooper, M.E.4
Ekinci, E.I.5
Coughlan, M.T.6
-
114
-
-
84919444097
-
Nutraceutical properties of dietary plants extracts: Prevention of diabetic nephropathy through inhibition of glycation and toxicity to erythrocytes and HEK293 cells
-
Tupe RS, Sankhe NM, Shaikh SA, et al. Nutraceutical properties of dietary plants extracts: prevention of diabetic nephropathy through inhibition of glycation and toxicity to erythrocytes and HEK293 cells. Pharm Biol 2015; 53(1): 40-50.
-
(2015)
Pharm Biol
, vol.53
, Issue.1
, pp. 40-50
-
-
Tupe, R.S.1
Sankhe, N.M.2
Shaikh, S.A.3
-
115
-
-
79958769222
-
Dietary nicotinic acid supplementation improves zinc uptake and offers hepatoprotection against oxidative damage
-
Tupe RS, Tupe SG, Agte VV. Dietary nicotinic acid supplementation improves zinc uptake and offers hepatoprotection against oxidative damage. Brit J Nutr 2011; 105: 1741-49.
-
(2011)
Brit J Nutr
, vol.105
, pp. 1741-1749
-
-
Tupe, R.S.1
Tupe, S.G.2
Agte, V.V.3
-
116
-
-
40849114632
-
Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy
-
Kobayashi S, Satoh M, Namikoshi T, et al. Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy. Clin Exp Nephrol 2008; 12 (2): 119-25.
-
(2008)
Clin Exp Nephrol
, vol.12
, Issue.2
, pp. 119-125
-
-
Kobayashi, S.1
Satoh, M.2
Namikoshi, T.3
-
117
-
-
84947017088
-
Glycation, carbonyl stress and AGEs inhibitors: Apatent review
-
Jahan H, Choudhary MI. Glycation, carbonyl stress and AGEs inhibitors: apatent review. Expert Opin Ther Pat 2015: 1-18.
-
(2015)
Expert Opin Ther Pat
, pp. 1-18
-
-
Jahan, H.1
Choudhary, M.I.2
-
118
-
-
1842852181
-
Effects of losartan and simvastatin on monocyte-derived microparticles in hypertensive patients with and without type 2 diabetes mellitus
-
Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T. Effects of losartan and simvastatin on monocyte-derived microparticles in hypertensive patients with and without type 2 diabetes mellitus. Clin Appl Thromb Hemost 2004; 10: 133-41.
-
(2004)
Clin Appl Thromb Hemost
, vol.10
, pp. 133-141
-
-
Nomura, S.1
Shouzu, A.2
Omoto, S.3
Nishikawa, M.4
Iwasaka, T.5
-
119
-
-
84860818001
-
Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the UK
-
Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the UK. Diabetes Care 2011; 34: 2220-4.
-
(2011)
Diabetes Care
, vol.34
, pp. 2220-2224
-
-
Abbott, C.A.1
Malik, R.A.2
Van Ross, E.R.3
Kulkarni, J.4
Boulton, A.J.5
-
120
-
-
33644787100
-
Microvascular disease in type 1 diabetes alters brain activation: A functional magnetic resonance imaging study
-
Wessels AM, Rombouts SA, Simsek S, et al. Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study. Diabetes 2006; 55: 334-40.
-
(2006)
Diabetes
, vol.55
, pp. 334-340
-
-
Wessels, A.M.1
Rombouts, S.A.2
Simsek, S.3
-
121
-
-
33845497001
-
Early involvement of the spinal cord in diabetic peripheral neuropathy
-
Selvarajah D, Wilkinson ID, Emery CJ, et al. Early involvement of the spinal cord in diabetic peripheral neuropathy. Diabetes Care 2006; 29: 2664-9.
-
(2006)
Diabetes Care
, vol.29
, pp. 2664-2669
-
-
Selvarajah, D.1
Wilkinson, I.D.2
Emery, C.J.3
-
122
-
-
84957939880
-
Diabetic neuropathic pain: Physiopathology and treatment
-
Schreiber AK, Nones CF, Reis RC, Chichorro JG, Cunha JM. Diabetic neuropathic pain: Physiopathology and treatment. World J Diabetes 2015; 6(3): 432-44.
-
(2015)
World J Diabetes
, vol.6
, Issue.3
, pp. 432-444
-
-
Schreiber, A.K.1
Nones, C.F.2
Reis, R.C.3
Chichorro, J.G.4
Cunha, J.M.5
-
123
-
-
0038353187
-
Corneal confocal microscopy: A non-invasive surrogate of nerve fiber damage andrepair in diabetic patients
-
Malik RA, Kallinikos P, Abbott CA, et al. Corneal confocal microscopy: a non-invasive surrogate of nerve fiber damage andrepair in diabetic patients. Diabetologia 2003; 46: 683-8.
-
(2003)
Diabetologia
, vol.46
, pp. 683-688
-
-
Malik, R.A.1
Kallinikos, P.2
Abbott, C.A.3
-
124
-
-
73249151401
-
Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes
-
Duran JB, Dobler D, Moffatt S, et al. Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes. Diabetes 2009; 58(12): 2893-2903.
-
(2009)
Diabetes
, vol.58
, Issue.12
, pp. 2893-2903
-
-
Duran, J.B.1
Dobler, D.2
Moffatt, S.3
-
125
-
-
84944887936
-
Knowledge of diabetic complications in patients with diabetes mellitus
-
Ullah F, Afridi AK, Rahim F, et al. Knowledge of diabetic complications in patients with diabetes mellitus. J Ayub Med Coll Abbottabad 2015; 27(2): 360-3.
-
(2015)
J Ayub Med Coll Abbottabad
, vol.27
, Issue.2
, pp. 360-363
-
-
Ullah, F.1
Afridi, A.K.2
Rahim, F.3
-
126
-
-
79960525595
-
Mechanism of diabetic neuropathy: Where are we now and where to go?
-
Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy: Where are we now and where to go? J Diabetes Investig 2011; 2(1): 18-32.
-
(2011)
J Diabetes Investig
, vol.2
, Issue.1
, pp. 18-32
-
-
Yagihashi, S.1
Mizukami, H.2
Sugimoto, K.3
-
127
-
-
3342991495
-
Intra epidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients
-
Pittenger GL, Ray M, Burcus NI, McNulty P, Basta B, Vinik AI. Intra epidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients. Diabetes Care 2004; 27: 1974-9.
-
(2004)
Diabetes Care
, vol.27
, pp. 1974-1979
-
-
Pittenger, G.L.1
Ray, M.2
Burcus, N.I.3
McNulty, P.4
Basta, B.5
Vinik, A.I.6
-
128
-
-
84956738997
-
From treatment to preventive actions: Improving function in patients with diabetic polyneuropathy
-
Sacco IC, Sartor CD. From treatment to preventive actions: improving function in patients with diabetic polyneuropathy. Diabetes Metab Res Rev 2016; 32 (Suppl 1): 206-12.
-
(2016)
Diabetes Metab Res Rev
, vol.32
, pp. 206-212
-
-
Sacco, I.C.1
Sartor, C.D.2
-
129
-
-
84983782277
-
Diabetic peripheral neuropathy and its determinants among patients attending a tertiary health care centre in mangalore, India
-
D'Souza M, Kulkarni V, Bhaskaran U, et al. Diabetic peripheral neuropathy and its determinants among patients attending a tertiary health care centre in mangalore, India. J Public Health Res 2015; 4(2): 450.
-
(2015)
J Public Health Res
, vol.4
, Issue.2
, pp. 450
-
-
D'souza, M.1
Kulkarni, V.2
Bhaskaran, U.3
-
130
-
-
84858786688
-
Quality of life and objective measures of diabetic neuropathy in a prospective placebocontrolled trial of ruboxistaurin and topiramate
-
Boyd A, Casselini C, Vinik E, Vinik A. Quality of life and objective measures of diabetic neuropathy in a prospective placebocontrolled trial of ruboxistaurin and topiramate. J Diabetes Sci Technol 2011; 5: 714-22.
-
(2011)
J Diabetes Sci Technol
, vol.5
, pp. 714-722
-
-
Boyd, A.1
Casselini, C.2
Vinik, E.3
Vinik, A.4
-
131
-
-
0037086889
-
Macrophage infiltration and death in the nerve during the early phases of experimental diabetic neuropathy: A process concomitant with endoneurial induction of IL-1betaand p75NTR
-
Conti G, Scarpini E, Baron P, et al. Macrophage infiltration and death in the nerve during the early phases of experimental diabetic neuropathy: a process concomitant with endoneurial induction of IL-1betaand p75NTR. J Neurol Sci 2002; 195: 35-40.
-
(2002)
J Neurol Sci
, vol.195
, pp. 35-40
-
-
Conti, G.1
Scarpini, E.2
Baron, P.3
-
132
-
-
0033970352
-
Pancreas and islet transplantation for patients with diabetes mellitus (Technical Review)
-
Robertson RP, Davis C, Larsen J, Stratta R. Sutherland DER: Pancreas and islet transplantation for patients with diabetes mellitus (Technical Review). Diabetes Care 2000; 23: 112-6.
-
(2000)
Diabetes Care
, vol.23
, pp. 112-116
-
-
Robertson, R.P.1
Davis, C.2
Larsen, J.3
Stratta, R.4
Sutherland, D.5
-
133
-
-
78651101410
-
Long-term results of pancreas transplantation in patients older than 50 years
-
Schenker P, Vonend O, Kruger B, et al. Long-term results of pancreas transplantation in patients older than 50 years. Transpl Int 2011; 24(2): 136-42.
-
(2011)
Transpl Int
, vol.24
, Issue.2
, pp. 136-142
-
-
Schenker, P.1
Vonend, O.2
Kruger, B.3
-
134
-
-
84862267906
-
Simultaneous pancreas and kidney (SPK) retransplantation in prior SPK recipients
-
LaMattina JC, Sollinger HW, Becker YT, Mezrich JD, Pirsch JD, Odorico JS. Simultaneous pancreas and kidney (SPK) retransplantation in prior SPK recipients. Clin Transplant 2012; 26(3): 495-501.
-
(2012)
Clin Transplant
, vol.26
, Issue.3
, pp. 495-501
-
-
Lamattina, J.C.1
Sollinger, H.W.2
Becker, Y.T.3
Mezrich, J.D.4
Pirsch, J.D.5
Odorico, J.S.6
-
135
-
-
63449138383
-
Kidney and pancreas transplantation in the United States, 1998-2007: Access for patients with diabetes and end-stage renal disease
-
McCullough KP, Keith DS, Meyer KH, Stock PG, Brayman KL, Leichtman AB. Kidney and pancreas transplantation in the United States, 1998-2007: access for patients with diabetes and end-stage renal disease. Am J Transplant 2009; 9(42): 894-906.
-
(2009)
Am J Transplant
, vol.9
, Issue.42
, pp. 894-906
-
-
McCullough, K.P.1
Keith, D.S.2
Meyer, K.H.3
Stock, P.G.4
Brayman, K.L.5
Leichtman, A.B.6
-
136
-
-
0035863216
-
The impact of simultaneous pancreas-kidney transplantation on long-term patient survival
-
Ojo AO, Meier HU, Hanson JA, et al. The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation 2001; 71(1): 82-90.
-
(2001)
Transplantation
, vol.71
, Issue.1
, pp. 82-90
-
-
Ojo, A.O.1
Meier, H.U.2
Hanson, J.A.3
-
137
-
-
80052265100
-
Guidelines for the diagnosis of antibody-mediated rejection in pancreas allograftsupdated banff grading schema
-
Drachenberg CB, Torrealba JR, Nankivell BJ, et al. Guidelines for the diagnosis of antibody-mediated rejection in pancreas allograftsupdated banff grading schema. Am J Transplant 2011; 11(9): 1792-802.
-
(2011)
Am J Transplant
, vol.11
, Issue.9
, pp. 1792-1802
-
-
Drachenberg, C.B.1
Torrealba, J.R.2
Nankivell, B.J.3
-
138
-
-
84886014207
-
Pancreas Transplant Alone: A procedure coming of age
-
Gruessner RW, Gruessner AC. Pancreas Transplant Alone: A procedure coming of age. Diabetes Care 2013; 36: 2440-7.
-
(2013)
Diabetes Care
, vol.36
, pp. 2440-2447
-
-
Gruessner, R.W.1
Gruessner, A.C.2
-
139
-
-
80052273861
-
The impact of pancreas transplantation on kidney allograft survival
-
Browne S, Gill J, Dong J, et al. The impact of pancreas transplantation on kidney allograft survival. Am J Transplant 2011; 11(9): 1951-8.
-
(2011)
Am J Transplant
, vol.11
, Issue.9
, pp. 1951-1958
-
-
Browne, S.1
Gill, J.2
Dong, J.3
-
140
-
-
33847736584
-
Human pancreatic digestive enzymes
-
Whitcomb DC, Lowe ME. Human pancreatic digestive enzymes. Dig Dis Sci 2007; 52(1): 1-17.
-
(2007)
Dig Dis Sci
, vol.52
, Issue.1
, pp. 1-17
-
-
Whitcomb, D.C.1
Lowe, M.E.2
-
141
-
-
33947709902
-
Islet vasculature as a regulator of endocrine pancreas function
-
Ballian N, Brunicardi FC. Islet vasculature as a regulator of endocrine pancreas function. World J Surg 2007; 31(4): 705-14.
-
(2007)
World J Surg
, vol.31
, Issue.4
, pp. 705-714
-
-
Ballian, N.1
Brunicardi, F.C.2
-
142
-
-
78649855645
-
Pancreas and kidney transplantation: Long term endocrine function
-
Mora M, Ricart MJ, Casamitjana R, et al. Pancreas and kidney transplantation: long term endocrine function. Clin Transplant 2010; 24(6): E23640.
-
(2010)
Clin Transplant
, vol.24
, Issue.6
, pp. 23640
-
-
Mora, M.1
Ricart, M.J.2
Casamitjana, R.3
-
143
-
-
84983782969
-
Kidney and pancreas transplantation
-
Townsend CM, Beauchamp RD, Evers BM, Mattox KL, Eds
-
Becker Y. Kidney and pancreas transplantation. In: Townsend CM, Beauchamp RD, Evers BM, Mattox KL, Eds. Sabiston Textbook of Surgery. 19th ed. Elsevier Saunders 2012; chap 28.
-
(2012)
Sabiston Textbook of Surgery. 19Th Ed. Elsevier Saunders
, pp. 28
-
-
Becker, Y.1
-
144
-
-
70350509208
-
Impact of pancreas transplantation on the quality of life of diabetic renal transplant recipients
-
Ziaja J, Bozek PD, Kowalik A, Krol R, Cierpka L. Impact of pancreas transplantation on the quality of life of diabetic renal transplant recipients. Transplant Proc 2009; 41(8): 3156-8.
-
(2009)
Transplant Proc
, vol.41
, Issue.8
, pp. 3156-3158
-
-
Ziaja, J.1
Bozek, P.D.2
Kowalik, A.3
Krol, R.4
Cierpka, L.5
-
145
-
-
35648972133
-
Pancreas-kidney and pancreas transplantation for the treatment of diabetes mellitus
-
Lipshutz GS, Wilkinson AH. Pancreas-kidney and pancreas transplantation for the treatment of diabetes mellitus. Endocrinol Metab Clin North Am 2007; 36: 1015-1038.
-
(2007)
Endocrinol Metab Clin North Am
, vol.36
, pp. 1015-1038
-
-
Lipshutz, G.S.1
Wilkinson, A.H.2
-
146
-
-
20444458775
-
Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair
-
Schmidt LC, Rossig L, Fichtlscherer S, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 2981-7.
-
(2005)
Circulation
, vol.111
, pp. 2981-2987
-
-
Schmidt, L.C.1
Rossig, L.2
Fichtlscherer, S.3
-
148
-
-
30744479430
-
Angiogenesis in life, disease and medicine
-
Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005; 438: 932-6.
-
(2005)
Nature
, vol.438
, pp. 932-936
-
-
Carmeliet, P.1
-
149
-
-
67349206322
-
Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis
-
Burchfield JS, Dimmeler S. Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis. Fibrogenesis Tissue Repair 2008; 1: 4.
-
(2008)
Fibrogenesis Tissue Repair
, vol.1
, pp. 4
-
-
Burchfield, J.S.1
Dimmeler, S.2
-
150
-
-
77950883548
-
The promise of cell based therapies for diabetic complications: Challenges andsolutions
-
Jarajapu YP, Grant MB. The promise of cell based therapies for diabetic complications: challenges andsolutions. Circ Res 2010; 106: 854-69.
-
(2010)
Circ Res
, vol.106
, pp. 854-869
-
-
Jarajapu, Y.P.1
Grant, M.B.2
-
151
-
-
4143052506
-
Endothelial progenitor cells: Characterization and role in vascular biology
-
Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004; 95: 343-53.
-
(2004)
Circ Res
, vol.95
, pp. 343-353
-
-
Urbich, C.1
Dimmeler, S.2
-
152
-
-
0038376000
-
Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration
-
Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003; 9: 702-12.
-
(2003)
Nat Med
, vol.9
, pp. 702-712
-
-
Rafii, S.1
Lyden, D.2
-
153
-
-
0345688062
-
Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells
-
Urbich C, Heeschen C, Aicher A, et al. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003; 108: 2511-6.
-
(2003)
Circulation
, vol.108
, pp. 2511-2516
-
-
Urbich, C.1
Heeschen, C.2
Aicher, A.3
-
154
-
-
0037058848
-
Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI)
-
Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002: 106; 3009-17.
-
(2002)
Circulation
, vol.106
, pp. 3009-3017
-
-
Assmus, B.1
Schachinger, V.2
Teupe, C.3
-
155
-
-
33645320601
-
Intracoronary administration of circulating blood-derived progenitor cells after recanalization of chronic coronary artery occlusion improves endothelial function
-
Erbs S, Linke A, Schuler G, Hambrecht R. Intracoronary administration of circulating blood-derived progenitor cells after recanalization of chronic coronary artery occlusion improves endothelial function. Circ Res 2006; 98: e48.32.
-
Circ Res 2006; 98
, vol.48
, pp. 32
-
-
Erbs, S.1
Linke, A.2
Schuler, G.3
Hambrecht, R.4
-
156
-
-
13544249606
-
Human mesenchymal stem cells modulate allogeneic immune cell responses
-
Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-22.
-
(2005)
Blood
, vol.105
, pp. 1815-1822
-
-
Aggarwal, S.1
Pittenger, M.F.2
-
158
-
-
0002330479
-
Pancreatic hormones and antidiabetic drugs, in basic and clinical pharmacology
-
Karam JH. Pancreatic hormones and antidiabetic drugs, in basic and clinical pharmacology. Appleton-Lange 1998; 684-703.
-
(1998)
Appleton-Lange
, pp. 684-703
-
-
Karam, J.H.1
-
159
-
-
77950891085
-
Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes
-
Phung OJ, Scholle JM, Talwar M, Coleman CI. Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. JAMA 2010; 303(14): 1410-8.
-
(2010)
JAMA
, vol.303
, Issue.14
, pp. 1410-1418
-
-
Phung, O.J.1
Scholle, J.M.2
Talwar, M.3
Coleman, C.I.4
-
160
-
-
84856736806
-
Upregulation of intestinal type 1 taste receptor 3 and sodium glucose luminal transporter-1 expression and increased sucrose intake in mice lacking gut microbiota
-
Swartz TD, Duca FA, de Wouters T, Sakar Y, Covasa M. Upregulation of intestinal type 1 taste receptor 3 and sodium glucose luminal transporter-1 expression and increased sucrose intake in mice lacking gut microbiota. Br J Nutr 2012; 107: 621-30.
-
(2012)
Br J Nutr
, vol.107
, pp. 621-630
-
-
Swartz, T.D.1
Duca, F.A.2
De Wouters, T.3
Sakar, Y.4
Covasa, M.5
-
161
-
-
23244458439
-
Regulation of blood glucose by hypothalamic pyruvate metabolism
-
Lam TK, Gutierrez JR, Pocai A, Rossetti L. Regulation of blood glucose by hypothalamic pyruvate metabolism. Science 2005; 309; 943-7.
-
(2005)
Science
, vol.309
, pp. 943-947
-
-
Lam, T.K.1
Gutierrez, J.R.2
Pocai, A.3
Rossetti, L.4
-
162
-
-
52749087007
-
The lipid messenger OEA links dietary fat intake to satiety
-
Schwartz GJ, Fu J, Astarita G, et al. The lipid messenger OEA links dietary fat intake to satiety. Cell Metab 2008; 8(4): 281-8.
-
(2008)
Cell Metab
, vol.8
, Issue.4
, pp. 281-288
-
-
Schwartz, G.J.1
Fu, J.2
Astarita, G.3
-
163
-
-
67650423944
-
GOAT links dietary lipids with the endocrine control of energy balance
-
Kirchner H, Gutierrez JA, Solenberg PJ, et al. GOAT links dietary lipids with the endocrine control of energy balance. Nat Med 2009; 15(7): 741-5.
-
(2009)
Nat Med
, vol.15
, Issue.7
, pp. 741-745
-
-
Kirchner, H.1
Gutierrez, J.A.2
Solenberg, P.J.3
-
164
-
-
56749164791
-
Nutrient sensing and inflammation in metabolic diseases
-
Hotamisligil GS, Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 2008; 8(12): 923-34.
-
(2008)
Nat Rev Immunol
, vol.8
, Issue.12
, pp. 923-934
-
-
Hotamisligil, G.S.1
Erbay, E.2
-
165
-
-
67849124833
-
Intestinal cholecystokinin controls glucose production through a neuronal network
-
Cheung GW, Kokorovic A, Lam CK, Chari M, Lam TK. Intestinal cholecystokinin controls glucose production through a neuronal network. Cell Metab 2009; 10(2): 99-109.
-
(2009)
Cell Metab
, vol.10
, Issue.2
, pp. 99-109
-
-
Cheung, G.W.1
Kokorovic, A.2
Lam, C.K.3
Chari, M.4
Lam, T.K.5
-
166
-
-
42549118500
-
Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production
-
Wang PY, Caspi L, Lam CK, et al. Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature 2008; 452(7190): 1012-6.
-
(2008)
Nature
, vol.452
, Issue.7190
, pp. 1012-1016
-
-
Wang, P.Y.1
Caspi, L.2
Lam, C.K.3
-
167
-
-
0344512367
-
Minireview: Nutrient sensing and the regulation of insulin action and energy balance
-
Obici S, Rossetti L. Minireview: nutrient sensing and the regulation of insulin action and energy balance. Endocrinology 2003; 144(12): 5172-8.
-
(2003)
Endocrinology
, vol.144
, Issue.12
, pp. 5172-5178
-
-
Obici, S.1
Rossetti, L.2
-
168
-
-
12344277552
-
Diabetes, obesity, and the brain
-
Schwartz MW, Porte D. Diabetes, obesity, and the brain. Science 2005; 307: 375-9.
-
(2005)
Science
, vol.307
, pp. 375-379
-
-
Schwartz, M.W.1
Porte, D.2
-
169
-
-
0034850444
-
Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and/type 2 diabetes mellitus: A physiological approach toward improved metabolic control
-
Weyer C, Maggs DG, Young AA, Kolterman OG. Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and/type 2 diabetes mellitus: a physiological approach toward improved metabolic control. Curr Pharm Des 2001; 7: 1353-73.
-
(2001)
Curr Pharm Des
, vol.7
, pp. 1353-1373
-
-
Weyer, C.1
Maggs, D.G.2
Young, A.A.3
Kolterman, O.G.4
-
170
-
-
0036236331
-
Pramlintide: An agent for glycemic control plus weight control
-
Riddle MC. Pramlintide: an agent for glycemic control plus weight control. Diabetes Technol Ther 2002; 4: 63-5.
-
(2002)
Diabetes Technol Ther
, vol.4
, pp. 63-65
-
-
Riddle, M.C.1
-
171
-
-
0037800669
-
Amylin replacement with pramlintide in type 1 and type 2 diabetes: A physiological approach to overcome barriers with insulin therapy
-
Buse JB, Weyer C, Maggs DG. Amylin replacement with pramlintide in type 1 and type 2 diabetes: a physiological approach to overcome barriers with insulin therapy. Clinical Diabetes 2002; 20: 137-44.
-
(2002)
Clinical Diabetes
, vol.20
, pp. 137-144
-
-
Buse, J.B.1
Weyer, C.2
Maggs, D.G.3
-
172
-
-
33746588255
-
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
-
Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006; 29(8): 1963-72.
-
(2006)
Diabetes Care
, vol.29
, Issue.8
, pp. 1963-1972
-
-
Nathan, D.M.1
Buse, J.B.2
Davidson, M.B.3
-
173
-
-
0043119715
-
Mealtime amylin replacement with pramlintide markedly improves postprandial glucose excursions when added to insulin lispro in patients with type 2 diabetes: A dose-timing study
-
Maggs DG, Weyer C, Crean J, et al. Mealtime amylin replacement with pramlintide markedly improves postprandial glucose excursions when added to insulin lispro in patients with type 2 diabetes: a dose-timing study. Diabetologia 2002; 45: A264.
-
(2002)
Diabetologia
, vol.45
, pp. 264
-
-
Maggs, D.G.1
Weyer, C.2
Crean, J.3
-
174
-
-
34248223285
-
Drucker DJ. Biology of incretins: GLP-1 and GIP
-
Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007; 132: 2131-57.
-
(2007)
Gastroenterology
, vol.132
, pp. 2131-2157
-
-
Baggio, L.L.1
-
175
-
-
35448986920
-
Gut-expressed gustducin and taste receptors regulate secretion of glucagonlikepeptide-1
-
Jang HJ, Kokrashvili Z, Theodorakis MJ, et al. Gut-expressed gustducin and taste receptors regulate secretion of glucagonlikepeptide-1. Proc Natl Acad Sci USA 2007; 104: 15069-74.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 15069-15074
-
-
Jang, H.J.1
Kokrashvili, Z.2
Theodorakis, M.J.3
-
176
-
-
27744541052
-
Exenatide augments firstand second-phase insulin secretion in response to intravenousglucose in subjects with type 2 diabetes
-
Fehse F, Trautmann M, Holst JJ, et al. Exenatide augments firstand second-phase insulin secretion in response to intravenousglucose in subjects with type 2 diabetes. J Clin Endocrinol Metab 2005; 90: 5991-7.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 5991-5997
-
-
Fehse, F.1
Trautmann, M.2
Holst, J.J.3
-
177
-
-
38549162147
-
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type2 diabetes treated for at least 3 years
-
Klonoff DC, Buse JB, Nielsen LL, et al. Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type2 diabetes treated for at least 3 years. Curr Med Res Opin 2008; 24: 275-86.
-
(2008)
Curr Med Res Opin
, vol.24
, pp. 275-286
-
-
Klonoff, D.C.1
Buse, J.B.2
Nielsen, L.L.3
-
178
-
-
33845489598
-
Efficacy and safety of the dipeptidylpeptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus
-
Raz I, Hanefeld M, Xu L, Caria C, Williams HD, Khatami H. Efficacy and safety of the dipeptidylpeptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus. Diabetologia 2006; 49: 2564-71.
-
(2006)
Diabetologia
, vol.49
, pp. 2564-2571
-
-
Raz, I.1
Hanefeld, M.2
Xu, L.3
Caria, C.4
Williams, H.D.5
Khatami, H.6
-
179
-
-
77952703708
-
The role of amylin in the control of energy homeostasis
-
Lutz TA. The role of amylin in the control of energy homeostasis. Am J Physiol Regul Integr Comp Physiol 2010; 298: R1475-84.
-
(2010)
Am J Physiol Regul Integr Comp Physiol
, vol.298
, pp. R1475-R1484
-
-
Lutz, T.A.1
-
180
-
-
84880327506
-
Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake
-
Mietlicki EG, Rupprecht LE, Olivos DR, et al. Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake. Neuropsychopharmacology 2013; 38: 1685-97.
-
(2013)
Neuropsychopharmacology
, vol.38
, pp. 1685-1697
-
-
Mietlicki, E.G.1
Rupprecht, L.E.2
Olivos, D.R.3
-
181
-
-
84859733684
-
GLP-1R and amylin agonism in metabolic disease: Complementary mechanisms and future opportunities
-
Roth JD, Erickson MR, Chen S, Parkes DG. GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities. Br J Pharmacol 2012; 166: 121-36.
-
(2012)
Br J Pharmacol
, vol.166
, pp. 121-136
-
-
Roth, J.D.1
Erickson, M.R.2
Chen, S.3
Parkes, D.G.4
-
182
-
-
62449325306
-
Implications of amylin receptor agonism: Integrated neuro hormonal mechanisms and therapeutic applications
-
Roth JD, Maier H, Chen S, Roland BL. Implications of amylin receptor agonism: integrated neuro hormonal mechanisms and therapeutic applications. Arch Neurol 2009; 66: 306-10.
-
(2009)
Arch Neurol
, vol.66
, pp. 306-310
-
-
Roth, J.D.1
Maier, H.2
Chen, S.3
Roland, B.L.4
-
183
-
-
0345374580
-
Glucagon-like peptide 1 inhibits cell apoptosis and improves glucoseresponsiveness of freshly isolated human islets
-
Farilla L, Bulotta A, Hirshberg B, et al. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucoseresponsiveness of freshly isolated human islets. Endocrinology 2003; 144: 5149-58.
-
(2003)
Endocrinology
, vol.144
, pp. 5149-5158
-
-
Farilla, L.1
Bulotta, A.2
Hirshberg, B.3
-
184
-
-
0141615898
-
Suppression of glucose production by GLP-1 independentof islet hormones: A novel extra pancreatic effect
-
Prigeon RL, Quddusi S, Paty B, Alessio DA. Suppression of glucose production by GLP-1 independentof islet hormones: a novel extra pancreatic effect. Am J Physiol Endocrinol Metab 2003; 285: E701-7.
-
(2003)
Am J Physiol Endocrinol Metab
, vol.285
, pp. E701-E707
-
-
Prigeon, R.L.1
Quddusi, S.2
Paty, B.3
Alessio, D.A.4
-
185
-
-
11144230786
-
Cell-specific expression of glucose-dependent-insulinotropic polypeptide is regulated by the transcription factor PDX-1
-
Jepeal LI, Fujitani Y, Boylan MO, Wilson CN, Wright CV, Wolfe MM. Cell-specific expression of glucose-dependent-insulinotropic polypeptide is regulated by the transcription factor PDX-1. Endocrinology 2005; 146: 383-91.
-
(2005)
Endocrinology
, vol.146
, pp. 383-391
-
-
Jepeal, L.I.1
Fujitani, Y.2
Boylan, M.O.3
Wilson, C.N.4
Wright, C.V.5
Wolfe, M.M.6
-
186
-
-
26244441014
-
The farnesoid X receptor: A molecular link between bile acid and lipid and glucose metabolism
-
Claudel T, Staels B, Kuipers F. The farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. Arterioscler Thromb Vasc Biol 2005; 25(10): 2020-31.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, Issue.10
, pp. 2020-2031
-
-
Claudel, T.1
Staels, B.2
Kuipers, F.3
-
187
-
-
34547150134
-
Rationale and design of a prospective clinical trial programto evaluate the glucose-lowering effects of colesevelam HCl in patients with type 2 diabetes mellitus
-
Bays HE, Cohen DE. Rationale and design of a prospective clinical trial programto evaluate the glucose-lowering effects of colesevelam HCl in patients with type 2 diabetes mellitus. Curr Med Res Opin 2007; 23(7): 1673-84.
-
(2007)
Curr Med Res Opin
, vol.23
, Issue.7
, pp. 1673-1684
-
-
Bays, H.E.1
Cohen, D.E.2
-
188
-
-
84983748882
-
Colesevelam HCl improves glucose metabolism and increases plasma glucagon like peptide 1 and glucose-dependent insulinotropic polypeptide concentrations in subjects with type 2 diabetes. Presented at the Annual Meeting of the European Association for the Study of Diabetes
-
Beysen C, Deines KC, Tsang EL, et al. Colesevelam HCl improves glucose metabolism and increases plasma glucagon like peptide 1 and glucose-dependent insulinotropic polypeptide concentrations in subjects with type 2 diabetes. Presented at the Annual Meeting of the European Association for the Study of Diabetes. Austria, 2009.
-
(2009)
Austria
-
-
Beysen, C.1
Deines, K.C.2
Tsang, E.L.3
-
189
-
-
53749091518
-
Endocrine Society. Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: An endocrine society clinical practice guideline
-
Rosenzweig JL, Ferrannini E, Grundy SM, et al. Endocrine Society. Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93: 3671-897.
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 3671-3897
-
-
Rosenzweig, J.L.1
Ferrannini, E.2
Grundy, S.M.3
-
190
-
-
77958179761
-
Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes
-
Gaziano JM, Cincotta AH, O'Connor CM, et al. Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes. Diabetes Care 2010; 33(7): 1503-8.
-
(2010)
Diabetes Care
, vol.33
, Issue.7
, pp. 1503-1508
-
-
Gaziano, J.M.1
Cincotta, A.H.2
O'connor, C.M.3
-
191
-
-
0032913283
-
Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists
-
Scislowski PW, Tozzo E, Zhang Y, Phaneuf S, Prevelige R, Cincotta AH. Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists. Int J Obes Relat Metab Disord 1999; 23: 425-31.
-
(1999)
Int J Obes Relat Metab Disord
, vol.23
, pp. 425-431
-
-
Scislowski, P.W.1
Tozzo, E.2
Zhang, Y.3
Phaneuf, S.4
Prevelige, R.5
Cincotta, A.H.6
-
192
-
-
32144448938
-
Standards of medical care in diabetes-2006
-
American Diabetes Association
-
American Diabetes Association. Standards of medical care in diabetes-2006. Diabetes Care 2006; 29(suppl 1): S4-42.
-
(2006)
Diabetes Care
, vol.29
, pp. 4-42
-
-
-
193
-
-
44649098307
-
Lipoprotein management in patients with cardiometabolic risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation
-
Brunzell JD, Davidson M, Furberg CD, et al. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care 2008; 31: 811-22.
-
(2008)
Diabetes Care
, vol.31
, pp. 811-822
-
-
Brunzell, J.D.1
Davidson, M.2
Furberg, C.D.3
-
194
-
-
14244251495
-
Farnesoid X receptor: A new player in glucose metabolism?
-
Cariou B, Duran-Sandoval D, Kuipers F, Staels B. Farnesoid X receptor: a new player in glucose metabolism? Endocrinology 2005; 146(3): 981-3.
-
(2005)
Endocrinology
, vol.146
, Issue.3
, pp. 981-983
-
-
Cariou, B.1
Duran-Sandoval, D.2
Kuipers, F.3
Staels, B.4
-
195
-
-
33751530003
-
Orphan receptor small heterodimer partner is an important mediator of glucose homeostasis
-
Wang L, Huang J, Saha P, et al. Orphan receptor small heterodimer partner is an important mediator of glucose homeostasis. Mol Endocrinol 2006; 20(11): 2671-81.
-
(2006)
Mol Endocrinol
, vol.20
, Issue.11
, pp. 2671-2681
-
-
Wang, L.1
Huang, J.2
Saha, P.3
-
196
-
-
77955657267
-
Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: The missing links. The Claude Bernard Lecture 2009
-
DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 2010; 53: 1270-87.
-
(2010)
Diabetologia
, vol.53
, pp. 1270-1287
-
-
Defronzo, R.A.1
-
197
-
-
0034647947
-
Dopamine and serotonin VMN release is related to feeding status in obese and lean Zucker rats
-
Meguid MM, Fetissov SO, Blaha V, Yang ZJ. Dopamine and serotonin VMN release is related to feeding status in obese and lean Zucker rats. Neuroreport 2000; 11: 2069-72.
-
(2000)
Neuroreport
, vol.11
, pp. 2069-2072
-
-
Meguid, M.M.1
Fetissov, S.O.2
Blaha, V.3
Yang, Z.J.4
-
198
-
-
77954242599
-
SGLT2 inhibition: A novel strategy for diabetes treatment
-
Chao EC, Henry RR. SGLT2 inhibition: a novel strategy for diabetes treatment. Nat Rev Drug Discov 2010; 9: 551-9.
-
(2010)
Nat Rev Drug Discov
, vol.9
, pp. 551-559
-
-
Chao, E.C.1
Henry, R.R.2
-
199
-
-
78651348100
-
Glucose transport by human renal Na+/D-glucose co-transporters SGLT1 and SGLT2
-
Hummel CS, Lu C, Loo DD, Hirayama BA, Voss AA, Wright EM. Glucose transport by human renal Na+/D-glucose co-transporters SGLT1 and SGLT2. Am J Physiol Cell Physiol 2011; 300: C14-21.
-
(2011)
Am J Physiol Cell Physiol
, vol.300
, pp. C14-C21
-
-
Hummel, C.S.1
Lu, C.2
Loo, D.D.3
Hirayama, B.A.4
Voss, A.A.5
Wright, E.M.6
-
200
-
-
75749094398
-
Familial renal glucosuria and SGLT2: From a Mendelian trait to a therapeutic target
-
Santer R, Calado J. Familial renal glucosuria and SGLT2: from a Mendelian trait to a therapeutic target. Clin J Am Soc Nephrol 2010; 5: 133-41.
-
(2010)
Clin J am Soc Nephrol
, vol.5
, pp. 133-141
-
-
Santer, R.1
Calado, J.2
-
201
-
-
78649957959
-
Management of type 2 diabetes: Evolving strategies for the treatment of patients with type 2 diabetes
-
Nyenwe EA, Jerkins TW, Umpierrez GE, Kitabchi AE. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism 2011; 60(1): 1-23.
-
(2011)
Metabolism
, vol.60
, Issue.1
, pp. 1-23
-
-
Nyenwe, E.A.1
Jerkins, T.W.2
Umpierrez, G.E.3
Kitabchi, A.E.4
-
202
-
-
77956921439
-
Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: A randomized, double-blind, placebocontrolled, phase 3 trial
-
Ferrannini E, Ramos SJ, Salsali A, Tang W, List JF. Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebocontrolled, phase 3 trial. Diabetes Care 2010; 33(10): 2217-24.
-
(2010)
Diabetes Care
, vol.33
, Issue.10
, pp. 2217-2224
-
-
Ferrannini, E.1
Ramos, S.J.2
Salsali, A.3
Tang, W.4
List, J.F.5
-
203
-
-
84858134830
-
From history to reality: Sodium glucose co-transporter 2 inhibitors-a novel therapy for type 2 diabetes mellitus
-
Nair S, Joseph F, Ewins D, et al. From history to reality: sodium glucose co-transporter 2 inhibitors-a novel therapy for type 2 diabetes mellitus. Pract Diabetes Int 2010; 27: 311-6.
-
(2010)
Pract Diabetes Int
, vol.27
, pp. 311-316
-
-
Nair, S.1
Joseph, F.2
Ewins, D.3
-
204
-
-
48249146624
-
Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats
-
Han S, Hagan DL, Taylor JR, et al. Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats. Diabetes 2008; 57: 1723-9.
-
(2008)
Diabetes
, vol.57
, pp. 1723-1729
-
-
Han, S.1
Hagan, D.L.2
Taylor, J.R.3
-
205
-
-
84892488179
-
Dapagliflozin 006 Study Group. Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: Efficacy and safety over 2 years
-
Wilding JP, Woo V, Rohwedder K, et al. Dapagliflozin 006 Study Group. Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years. Diabetes Obes Metab 2013; 16(2): 124-36.
-
(2013)
Diabetes Obes Metab
, vol.16
, Issue.2
, pp. 124-136
-
-
Wilding, J.P.1
Woo, V.2
Rohwedder, K.3
-
206
-
-
84898791440
-
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone
-
Forst T, Guthrie R, Goldenberg R, et al. Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone. Diabetes Obes Metab 2014; 16(5): 467-77.
-
(2014)
Diabetes Obes Metab
, vol.16
, Issue.5
, pp. 467-477
-
-
Forst, T.1
Guthrie, R.2
Goldenberg, R.3
-
207
-
-
77956921439
-
Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: A randomized, doubleblind, placebo-controlled, phase 3 trial
-
Ferrannini E, Ramos SJ, Salsali A, Tang W, List JF. Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, doubleblind, placebo-controlled, phase 3 trial. Diabetes Care 2010; 33(10): 2217-24.
-
(2010)
Diabetes Care
, vol.33
, Issue.10
, pp. 2217-2224
-
-
Ferrannini, E.1
Ramos, S.J.2
Salsali, A.3
Tang, W.4
List, J.F.5
-
208
-
-
84858020943
-
Effects ofdapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients withtype 2 diabetes mellitus with inadequate glycemic control on metformin
-
Bolinder J, Ljunggren O, Kullberg J, et al. Effects ofdapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients withtype 2 diabetes mellitus with inadequate glycemic control on metformin. J Clin Endocrinol Metab 2012; 97: 102031.
-
(2012)
J Clin Endocrinol Metab
, vol.97
, Issue.10
, pp. 2031
-
-
Bolinder, J.1
Ljunggren, O.2
Kullberg, J.3
-
209
-
-
84983752278
-
FDA briefing document: NDA 202293. Dapagliflozin tablets, 5 and 10 mg
-
US Food and Drug Administration
-
US Food and Drug Administration. FDA briefing document: NDA 202293. Dapagliflozin tablets, 5 and 10 mg. Advisory Committee meeting 2011; 19.
-
(2011)
Advisory Committee Meeting
, pp. 19
-
-
|